机译:市场,监管格局以及与数字医疗相关的临床试验的现状分析
PBG Healthcare Consulting, University of Pennsylvania, Philadelphia, PA 19104, USA;
PBG Healthcare Consulting, University of Pennsylvania, Philadelphia, PA 19104, USA;
PBG Healthcare Consulting, University of Pennsylvania, Philadelphia, PA 19104, USA;
PBG Healthcare Consulting, University of Pennsylvania, Philadelphia, PA 19104, USA;
PBG Healthcare Consulting, University of Pennsylvania, Philadelphia, PA 19104, USA;
PBG Healthcare Consulting, University of Pennsylvania, Philadelphia, PA 19104, USA;
PBG Healthcare Consulting, University of Pennsylvania, Philadelphia, PA 19104, USA;
PBG Healthcare Consulting, University of Pennsylvania, Philadelphia, PA 19104, USA;
Pennsylvania Drug Discovery Institute, Doylestown, PA 18902, USA;
Digital health; healthcare; FDA regulation; clinical trials; pre-market approvals; FDA pre-certification program;
机译:肥胖衍生的干细胞在美学手术中:目前临床试验,知识产权和监管景观的混合方法评价
机译:关于:染色衍生的审美干细胞:一种混合方法评价目前的临床试验,知识产权和监管景观
机译:数字健康中未公开发表率和注册随机临床试验的特征:跨部门分析
机译:互连智能手机,图像分析服务器和临床试验中的病例报告表,以在临床试验中自动跟踪皮肤病变
机译:健康 有关的研究, 博士学位授权一级 临床心理学 课程 :目前 景观 掠影
机译:节点。健康会议报告和小组讨论 - Covid-19期间FDA不断变化的数字健康技术和数字健康创新的监管景观:与Aenor Sawyer主持的埃里克托普尔和巴克尔帕尔的讨论
机译:PMU95临床试验数字健康干预景观:描述性分析